Shanghai Pharmaceuticals Holding Co., Ltd (2607.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 37.91B |
| Enterprise Value | 54.66B |
| P/E Ratio | 12.57 |
| PEG Ratio | -0.6 |
| Price/Sales Ratio | 0.21 |
| Price/Book Ratio | 0.77 |
| Enterprise/Revenue | 0.32 |
| Enterprise/EBITDA | 7.72 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.02 |
| Operating Margin | 0.03 |
AD
Management Effectiveness
| Return On Assets | 0.02 |
| Return On Equity | 0.06 |
Income Statement
| Revenue | 283.58B |
| Revenue/Share | 78.06 |
| Gross Profit | 30.42B |
| EBITDA | 14.37B |
| Net Income | 5.72B |
| Diluted EPS | 1.54 |
Balance Sheet
| Total Cash | 45.98B |
| Total Cash/Share | 12.4 |
| Total Debt | 65.92B |
| Total Debt/Equity | 0.84 |
| Current Ratio | 1.34 |
| Book Value Per Share | 25.16 |
Price History
| 52-Week Change | -11.26 |
| 52-Week High | 12.46 |
| 52-Week Low | 10.7 |
| Moving Average 50 Days | 11.48 |
| Moving Average 200 Days | 11.69 |
Statistics
| Average Volume | 1.78M |
| Shares Outstanding | 5.8B |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.57 |
| Trailing Annual Dividend Yield | 3.51 |
| Payout Ratio | 0.62 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
